# Delayed Initiation of Olaparib Maintenance Therapy in Platinum Sensitive Recurrent Ovarian Cancer

> **NCT04377087** · PHASE2 · TERMINATED · sponsor: **Sarah E Taylor** · enrollment: 3 (actual)

## Conditions studied

- Ovarian Cancer

## Interventions

- **DRUG:** Olaparib

## Key facts

- **NCT ID:** NCT04377087
- **Lead sponsor:** Sarah E Taylor
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-06-29
- **Primary completion:** 2023-05-31
- **Final completion:** 2023-05-31
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** Slow enrollment
- **Last updated:** 2024-08-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04377087

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04377087, "Delayed Initiation of Olaparib Maintenance Therapy in Platinum Sensitive Recurrent Ovarian Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04377087. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*